[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$ucbjy](/topic/$ucbjy)

### Top Social Posts

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Stocks she sold: Healthcare & Pharma: $UNH $LLY $MRK $GILD $JNJ $CVS $CI $AZN $GSK $HLN $ELAN $UCBJY $TMO $MCK Industrials Energy & Materials: $XOM $CVX $COP $SHEL $DE $CAT $ETN $EMR $TT $URI $TOL $FDX $UPS $GE $GEV $BA $NSC $UNP $WAB $TDG $MLM $CRH $MOS $NEM $NTR $IMO $CNQ $FQVLF"  
[X Link](https://x.com/GovStockTracker/status/1976636000928440468) [@GovStockTracker](/creator/x/GovStockTracker) 2025-10-10T13:08Z 9704 followers, XXX engagements


"Needhamthe PT on $STOK to $XX from $XX and reiterated at a Buy rating after STOK presented new zorevuneren OLE data in Dravet Syndrome (DS) at the 54th Child Neurology Society (CNS) annual meeting yesterday. $BIIB $JAZZ UCBJY UCBJF Needham said in its note: The new data showed 1) patients treated with zorevunersen had continued improvements in clinical outcomes through X years and 2) an analysis of patients in the OLE who received a similar dosing regimen as the ongoing Ph3 trial continued to show improvements in the Vineland-3 (cognition & behavior) at X years vs. a DS natural history study."  
[X Link](https://x.com/Quantumup1/status/1976615201718903033) [@Quantumup1](/creator/x/Quantumup1) 2025-10-10T11:46Z 3846 followers, 1793 engagements


"Oppenheimer reiterated $IMVT Outperform/$54. $ROIV $ARGX $JNJ $VRDN $AMGN $RHHBY $TAK $TRML Oppenheimer said: $IMVT announced inspiring remission data in uncontrolled Graves' patients that showed a high rate of durable responses off batoclimab which the company detailed in a call w/slides. About XX% (17/21) of patients followed after the positive Phase 2's treatment portion maintained normal thyroid hormone levels six months off bato of whom half (8/17) achieved remission without anti-thyroid drugs. These results not only underscore FcRn inhibition as a means to address the 25-30% of Graves'"  
[X Link](https://x.com/Quantumup1/status/1963651815343628456) [@Quantumup1](/creator/x/Quantumup1) 2025-09-04T17:14Z 3844 followers, 2918 engagements


"BTIG $STOK's PT to $XX from $XX reiterated at a Buy and said that the 36-month data for Zorevunersen (STK-001) seems to bury any remaining questions. $UCBJY $UCBJF $JAZZ $BIIB $ACAD $DNLI BTIG said in its note:"  
[X Link](https://x.com/Quantumup1/status/1957523671742050745) [@Quantumup1](/creator/x/Quantumup1) 2025-08-18T19:23Z 3846 followers, 4067 engagements